Tag:

brain cancer

Latest Headlines

Latest Headlines

Nonviral gene therapy shrinks brain tumors in rats

A global team of scientists working with Johns Hopkins' Jordan Green has developed a new nonviral gene therapy for brain cancer, successfully testing it in the lab in cell lines as well as rat models for the disease.

New drug target ID'd for aggressive cases of brain cancer

Mutations in the TCF12 gene, which plays a big role in developing brains in the embryo, has been tied to an aggressive form of brain cancer.

Cedars-Sinai team develops delivery-Dx combo nanomed for brain cancer

Researchers in Los Angeles have developed a nanomed that can take on two crucial roles--diagnosing brain tumors and delivering the drugs that can take them down.

Gold nanoparticles deliver RNA to the brain to suppress cancer genes

Researchers at Northwestern University have put together a nanostructure capable of shuttling a new RNA molecule across the blood-brain barrier to reach tumor cells in mice with glioblastoma multiforme, a particularly aggressive form of brain cancer.

Targeted mitochondrial attack destroys glioma cells in preclinical study

Zeroing in on an enzyme that is over-expressed in brain tumor cells, two investigators at Houston Methodist say they have developed a new treatment for gliomas that has cleared its preclinical testing and should be ready for human testing within the next one to two years.

Glioblastoma project IDs a new approach to brain cancer and understanding EGFR

Investigators say that they've identified a pathway that can be used to target brain tumor stem cells, adding to potential therapeutic strategies for the aggressive disease glioblastoma.

Monteris nabs $30M to grow its less invasive neurosurgery tech

Canada's Monteris Medical announced a $30 million equity financing for its NeuroBlate robotic neurosurgical system to ablate, or destroy using heat, brain lesions like primary and metastatic tumors. 

UC San Diego biomarker discovery could boost brain cancer drug's success rate

Researchers in California believe they've zeroed in on biomarkers--microRNAs--that will help determine who will respond best to the treatment and help boost its success rate.

Agenus brain cancer vaccine boosts survival in PhII trial

Patients with a lethal form of brain cancer lived nearly twice as long as expected after receiving Agenus' ($AGEN) Prophage vaccine in a Phase II study, according to the company.

ASCO preview: What's the outlook for cancer vaccines?

The cancer vaccine field has seen its share of late-stage disappointments and outright flops, but a number of hopefuls are lining up to present new research backing their experimental shots at this year's upcoming American Society of Clinical Oncology Annual Meeting in Chicago.